Edition:
India

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

93.78USD
22 Feb 2018
Change (% chg)

$0.58 (+0.62%)
Prev Close
$93.20
Open
$93.79
Day's High
$94.81
Day's Low
$93.60
Volume
211,999
Avg. Vol
208,809
52-wk High
$104.78
52-wk Low
$67.07

Select another date:

Tue, Jan 23 2018

BRIEF-ResMed Q2 Gaap Earnings Per Share $0.07

* ANNOUNCES RESULTS FOR THE SECOND QUARTER OF FISCAL YEAR 2018

NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

UPDATE 1-NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

Dec 12 New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

NZ's Fisher & Paykel sues Resmed in patent dispute

Dec 12 New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

BRIEF-Resmed Inc elects Karen Drexler to its board of directors

* Resmed elects Karen Drexler to its board of directors Source text for Eikon: Further company coverage:

BRIEF-Resmed updates on United Kingdom case with Fisher & Paykel​

* Ruling has no impact on Resmed's commercial operations in UK​

UPDATE 1-Fisher & Paykel says UK court rules rival Resmed's patent is invalid

* UK court rules Resmed's patent for mask invalid - F&P Healthcare

Fisher & Paykel says UK court rules rival Resmed's patent is invalid

WELLINGTON, Nov 13 A British court has ruled that a patent held by health appliance firm Resmed Inc for a mask that treats sleep apnea was invalid, rival firm Fisher & Paykel Healthcare said on Monday.

Select another date: